FDA’s Digital Health Center Director Says GenAI Tools Should Be Evaluated Like Physicians

FDA official Rick Abramson argues that generative AI-enabled medical devices should be assessed using standards similar to those applied to human clinicians due to their evolving, adaptive behavior. Rick Abramson, director of the FDA’s Digital Health Center of Excellence and a radiologist by...